The Pharmacokinetics of Intradialytic Administration of Eculizumab in an Infant-Reference-Cited by-同舟云学术

The Pharmacokinetics of Intradialytic Administration of Eculizumab in an Infant

Published:2015-12 Issue:6 Volume:66 Page:1105-1106
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Lee Ji,Imani Peace,Geer Jessica,Braun Michael,Srivaths Poyyapakkam,Orjuela Alvaro

Publisher

Elsevier BV

Subject

Nephrology

Reference7 articles.

1. Atypical hemolytic–uremic syndrome;Noris;N Engl J Med,2009

2. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype;Bresin;J Am Soc Nephrol,2013

3. Soliris (eculizumab) package insert. http://www.soliris.net/indications/soliris_pi.pdf. Accessed April 9, 2015.

4. Cambridge Biomedical. Eculizumab in serum. http://www.cambridgebiomedical.com/Home/DocumentManager/tabid/155/Default.aspx?EntryId=1960. Accessed March 2, 2015.

5. Efficacy and safety of eculizumab in children and adolescents with paroxysmal nocturnal hemoglobinuria;Reiss;Pediatr Blood Cancer,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe proteinuria (but not being on dialysis) may be associated with initial inadequate complement inhibition and delayed hematological response to eculizumab therapy;Journal of Nephrology;2023-12-22

2. Tolerance of dinutuximab therapy for treatment of high‐risk neuroblastoma in two patients with end‐stage renal disease on dialysis;Pediatric Blood & Cancer;2020-12-31

3. Indications of plasma exchanges in combination with intravenous immunoglobulins or therapeutic monoclonal antibodies. How to combine them?;La Presse Médicale;2019-11

4. Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report;BMC Nephrology;2017-07-18